Breast cancer (BC) has different clinical manifestations due to its diverse mechanism of
action that has created many challenges to choosing appropriate treatment. Recent findings …

Autophagy is a major catabolic pathway in a eukaryotic cell, employed for cellular self-
degradation of obsolete or damaged cytoplasmic components serving as a major quality …

Cancer is considered an age-related disease that, over the next 10 years, will become the
most prevalent health problem worldwide. Although cancer therapy has remarkably …

Breast cancer (BC) is a potentially life‐threatening malignant tumor that still causes high
mortality among women. One of the mechanisms through which cancer development could …

Breast cancer is the second most common cancer globally and the pioneering cause of
mortality among women. It usually begins from the ducts or lobules, referred to as ductal …

Although triple negative breast cancer (TNBC) is a small percentage of all breast cancers, to
date, TNBC is one of the most challenging types of breast cancer for basic and clinic …

Despite an increase in the incidence of breast cancer worldwide, overall prognosis has
been consistently improving owing to the development of multiple targeted therapies and …

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancers which
constitutes about 15% of all breast cancer cases and characterized by negative expression …

Macroautophagy (herein referred to as autophagy) is a complex catabolic process
characterized by the formation of double-membrane vesicles called autophagosomes …

Breast cancer is a heterogeneous disease consisting of different biological subtypes, with
differences in terms of incidence, response to diverse treatments, risk of disease …